Seroprevalence kinetics of SARS-CoV-2 antibodies in pediatric patients visiting a hospital during COVID-19 pandemic in Japan.

Seroprevalence kinetics of SARS-CoV-2 antibodies in pediatric patients visiting a hospital during COVID-19 pandemic in Japan.

Publication date: Sep 19, 2023

Children infected with SARS-CoV-2 are often asymptomatic or have mild symptoms. The studies on the seroprevalence kinetics of SARS-CoV-2 antibodies in children are limited. We conducted a cross-sectional survey of the positive rate of the SARS-CoV-2 IgG in pediatric patients without suspected COVID-19 infection between January 2007 and March 2022. We defined the serum samples from the pre-pandemic and pandemic groups (1st-6th waves). Totally, 2557 samples were collected and no samples from the pre-pandemic group or the 1st-4th waves were positive for IgG. There were 4/661 and 16/373 positives at the 5th and 6th waves, respectively. At the 5th wave, the prevalence of IgG was 1. 3% in children aged 1-4 years. At the 6th wave, in children

Concepts Keywords
Antibodies Children
Japan COVID-19 pandemic
March SARS-CoV-2 antibody
Pandemic Seroprevalence
Pediatric

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH infection

Original Article

(Visited 1 times, 1 visits today)